ARCHIVES

Zaltrap Economics 101: The Pricing And Repricing of an Expensive Drug

This article is from The Cancer Letter archive.

Vol. 38 No. 43 | November 16, 2012

Download PDF Visit The Full Archive

Related Articles

New NIH Grant Program or Young Investigators

October 8, 2010

CDC: Lung Cancer Rates Drop Following Anti-Smoking Efforts

January 17, 2014

In Brief: AACR, ASCO Meeting In Toronto; Regional Planners Threaten Cancer Program Delays

April 9, 1976

In Brief: NCAB To Hear NCOG Appeal; FDA Renege On New Toxicology Protocol, Holds Up INDs

April 24, 1981

Sponsors Wanted: FDA Offers Incentives For Pediatric Oncology Drug Development.

March 10, 2000

Funding For Groups, Working With Industry, Still Unresolved

June 12, 1998